Based in Cambridge, MA, STRM.BIO is a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapy in a better way: simpler, safer, practical.
Our work will open the door to the future of medicine for patients living with rare diseases worldwide.